Eli Lilly launches program to expand employer coverage of obesity drugs

Eli Lilly (LLY) announced the launch of its Employer Connect platform. Lilly’s platform expands choice, empowering employers to coordinate with independent program administrators to develop solutions that enable employee access to obesity management medicines. Lilly’s employer access program is launching with over fifteen independent program administrators and nationwide pharmacy support delivered through a dedicated network, including dispensing pharmacies HealthDyne and CenterWell. These administrators range from organizations offering low-cost benefits administration to more holistic solutions that provide obesity care and wraparound support services. Through this employer platform, Lilly’s Zepbound KwikPen is available from Lilly to network pharmacies at a discounted price of $449 for all doses. Final cost to the employer may vary based on their choice of pharmacy and program administrator; and out-of-pocket patient costs for employees will vary based on the costshare model an employer chooses and the dispensing and service fees agreed to with independent program administrators.